{
  "case_id": "case_0013",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 27.79,
    "sex": "Male",
    "genderIdentity": "Transgender Male",
    "ancestry": "Oceanian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve (cranial nerve II).\n  \nMore precision is possible than: 'left thoracic spinal cord'.  \nNamely: left T8 spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "left T8 myelopathy",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "thoracic spinal cord",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [
          [
            "left thoracic spinal cord",
            "left T8 myelopathy"
          ]
        ],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 1,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 0.5,
        "proportion_imprecise": 0.5,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Neuromyelitis optica spectrum disorder (AQP4-IgG positive); MOG antibody\u2013associated disease; Compressive thoracic myelopathy (e.g., meningioma); Neurosarcoidosis; Autoimmune myelitis secondary to SLE/Sj\u00f6gren; Vitamin B12 deficiency (subacute combined degeneration); Syphilis-related myelitis/optic neuropathy; HTLV-1\u2013associated myelopathy",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing\u2013remitting multiple sclerosis",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "MOG antibody\u2013associated disease",
          "Compressive thoracic myelopathy (e.g., meningioma)",
          "Neurosarcoidosis",
          "Autoimmune myelitis secondary to SLE/Sj\u00f6gren",
          "Vitamin B12 deficiency (subacute combined degeneration)",
          "Syphilis-related myelitis/optic neuropathy",
          "HTLV-1\u2013associated myelopathy"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Allergic rhinitis": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Allergic rhinitis"
        ],
        "additional_diagnoses": [
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "MOG antibody\u2013associated disease",
          "Compressive thoracic myelopathy (e.g., meningioma)",
          "Neurosarcoidosis",
          "Autoimmune myelitis secondary to SLE/Sj\u00f6gren",
          "Vitamin B12 deficiency (subacute combined degeneration)",
          "Syphilis-related myelitis/optic neuropathy",
          "HTLV-1\u2013associated myelopathy"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Orbits and Thoracic Spine and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain, orbits, and entire spinal cord with gadolinium",
          "Visual evoked potentials",
          "Optical coherence tomography",
          "CSF cell count and differential",
          "CSF protein",
          "CSF glucose",
          "CSF oligoclonal bands and IgG index",
          "Serum aquaporin-4 IgG",
          "Serum MOG IgG",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Vitamin B12",
          "Folate",
          "Thyroid-stimulating hormone",
          "Serum ACE",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "SSA/Ro antibody",
          "SSB/La antibody",
          "HIV antigen/antibody",
          "Syphilis serology (treponemal test and RPR)",
          "HTLV-1/2 antibodies",
          "Chest X-ray"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 3,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute severe optic neuritis and myelitis",
              "Improves speed of neurological recovery",
              "Standard first-line therapy for inflammatory demyelinating relapse"
            ]
          },
          {
            "treatment": "Proton pump inhibitor during high-dose steroids",
            "timing": "Start Now",
            "reasons": [
              "Gastric protection with corticosteroids",
              "Reduces risk of steroid-related dyspepsia/ulcer"
            ]
          },
          {
            "treatment": "Venous thromboembolism prophylaxis and early physiotherapy",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility from spastic paraparesis",
              "Prevents deconditioning and DVT"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 exchanges)",
            "timing": "Delay",
            "reasons": [
              "Escalate if poor response to steroids within 48\u201372 hours",
              "Indicated early if AQP4-IgG positive or vision remains hand movements only"
            ]
          },
          {
            "treatment": "High-efficacy MS disease-modifying therapy (e.g., ocrelizumab) or NMOSD-directed therapy if indicated",
            "timing": "Delay",
            "reasons": [
              "Initiate after diagnostic confirmation and serology results",
              "Requires infection screening and vaccination review"
            ]
          },
          {
            "treatment": "Baclofen for spasticity as needed",
            "timing": "Delay",
            "reasons": [
              "Introduce after acute phase if persistent spasticity limits function",
              "Dose titration guided by response and side effects"
            ]
          },
          {
            "treatment": "Urgent neurosurgical consultation for decompression if MRI shows cord compression",
            "timing": "Delay",
            "reasons": [
              "Definitive treatment for compressive myelopathy",
              "Only indicated if imaging identifies a structural lesion"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute severe optic neuritis and myelitis",
              "Improves speed of neurological recovery",
              "Standard first-line therapy for inflammatory demyelinating relapse"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "High-efficacy MS disease-modifying therapy (e.g., ocrelizumab) or NMOSD-directed therapy if indicated",
            "timing": "Delay",
            "reasons": [
              "Initiate after diagnostic confirmation and serology results",
              "Requires infection screening and vaccination review"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 3,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 2,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.6666666666666666,
          "proportion_reasons_missed": 0.3333333333333333
        }
      }
    }
  }
}